Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Nat Commun ; 10(1): 5779, 2019 12 18.
Article in English | MEDLINE | ID: mdl-31852955

ABSTRACT

Neuroinflammation is often associated with blood-brain-barrier dysfunction, which contributes to neurological tissue damage. Here, we reveal the pathophysiology of Susac syndrome (SuS), an enigmatic neuroinflammatory disease with central nervous system (CNS) endotheliopathy. By investigating immune cells from the blood, cerebrospinal fluid, and CNS of SuS patients, we demonstrate oligoclonal expansion of terminally differentiated activated cytotoxic CD8+ T cells (CTLs). Neuropathological data derived from both SuS patients and a newly-developed transgenic mouse model recapitulating the disease indicate that CTLs adhere to CNS microvessels in distinct areas and polarize granzyme B, which most likely results in the observed endothelial cell injury and microhemorrhages. Blocking T-cell adhesion by anti-α4 integrin-intervention ameliorates the disease in the preclinical model. Similarly, disease severity decreases in four SuS patients treated with natalizumab along with other therapy. Our study identifies CD8+ T-cell-mediated endotheliopathy as a key disease mechanism in SuS and highlights therapeutic opportunities.


Subject(s)
Central Nervous System/blood supply , Endothelium, Vascular/pathology , Microvessels/pathology , Susac Syndrome/immunology , T-Lymphocytes, Cytotoxic/immunology , Adult , Animals , Cell Adhesion/drug effects , Cell Adhesion/immunology , Central Nervous System/immunology , Central Nervous System/pathology , Disease Models, Animal , Endothelium, Vascular/drug effects , Endothelium, Vascular/immunology , Female , Humans , Integrin alpha4/antagonists & inhibitors , Integrin alpha4/metabolism , Male , Mice, Transgenic , Microvessels/drug effects , Microvessels/immunology , Middle Aged , Natalizumab/pharmacology , Natalizumab/therapeutic use , Susac Syndrome/blood , Susac Syndrome/drug therapy , Young Adult
2.
J Neuroinflammation ; 11: 46, 2014 Mar 08.
Article in English | MEDLINE | ID: mdl-24606999

ABSTRACT

BACKGROUND: Susac syndrome (SuS) is a rare disorder thought to be caused by autoimmune-mediated occlusions of microvessels in the brain, retina and inner ear leading to central nervous system (CNS) dysfunction, visual disturbances due to branch retinal artery occlusions (BRAO), and hearing deficits. Recently, a role for anti-endothelial cell antibodies (AECA) in SuS has been proposed. OBJECTIVES: To report the clinical and paraclinical findings in the largest single series of patients so far and to investigate the frequency, titers, and clinical relevance of AECA in SuS. PATIENTS AND METHODS: A total of 107 serum samples from 20 patients with definite SuS, 5 with abortive forms of SuS (all with BRAO), and 70 controls were tested for AECA by immunohistochemistry employing primate brain tissue sections. RESULTS: IgG-AECA >1:100 were detected in 25% (5/20) of patients with definite SuS and in 4.3% (3/70) of the controls. Median titers were significantly higher in SuS (1:3200, range 1:100 to 1:17500) than in controls (1:100, range 1:10 to 1:320); IgG-AECA titers >1:320 were exclusively present in patients with SuS; three controls had very low titers (1:10). Follow-up samples (n = 4) from a seropositive SuS patient obtained over a period of 29 months remained positive at high titers. In all seropositive cases, AECA belonged to the complement-activating IgG1 subclass. All but one of the IgG-AECA-positive samples were positive also for IgA-AECA and 45% for IgM-AECA. SuS took a severe and relapsing course in most patients and was associated with bilateral visual and hearing impairment, a broad panel of neurological and neuropsychological symptoms, and brain atrophy in the majority of cases. Seropositive and seronegative patients did not differ with regard to any of the clinical or paraclinical parameters analyzed. CONCLUSIONS: SuS took a severe and protracted course in the present cohort, resulting in significant impairment. Our finding of high-titer IgG1 and IgM AECA in some patients suggest that humoral autoimmunity targeting the microvasculature may play a role in the pathogenesis of SuS, at least in a subset of patients. Further studies are warranted to define the exact target structures of AECA in SuS.


Subject(s)
Autoantibodies/blood , Susac Syndrome/blood , Susac Syndrome/diagnosis , Adolescent , Adult , Aged , Cognition Disorders/etiology , Connective Tissue Diseases/blood , Hearing Disorders/etiology , Humans , Immunoglobulin G/blood , International Cooperation , Leukocyte Count , Lupus Vasculitis, Central Nervous System/blood , Middle Aged , Multiple Sclerosis/blood , Serologic Tests , Susac Syndrome/complications , Vision Disorders/etiology , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...